مباشر

FierceBiotechTransforming neurodegenerative disease treatment FierceBiotechAdvances and Opportunities in Dual Chamber Injectables FierceBiotechAchieving Effective Manufacturing Scaleup for Clinical and Commercial Success FierceBiotechUtilizing AI to Facilitate Combination Product Development FierceBiotechEnsuring Sustainability Throughout Drug and Device Development FierceBiotechUsing Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain Endpoints NewsCDER chief Høeg expected to leave FDA, according to source Clinical OMICsPPG-Derived Digital Biomarker Developed for Peripheral Artery Disease Detection Charles RiverCharles River Laboratories stock (US1591881009): recent earnings and outlook under the microscope - AD HOC NEWS Clinical OMICsAntibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer Clinical OMICsExchange Marketplace Launched to Help Stalled Cell and Gene Therapies Clinical OMICsSingle Psilocybin Dose Relieves Depression for Over Three Months

FierceBiotech ١٥ مايو ٢٠٢٦

Advances and Opportunities in Dual Chamber Injectables

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess...

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess in the development of liquid/liquid and liquid/lyo dual chamber systems.